ArticleTranslational lung cancer research2026
Trophoblast cell-surface antigen 2-targeted "sacituzumab tirumotecan": a new approach for epidermal growth factor receptor-tyrosine kinase inhibitor-resistant non-small cell lung cancer.
Kimio YonesakaPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.